57 results
8-K
EX-10.1
DYAI
Dyadic International Inc., DE
17 Dec 21
Dyadic Announces Research, License and Collaboration Agreement with Janssen
7:10am
of the Process and with the training of the personnel of Janssen (or its Affiliate, Subcontractor, or Permitted Representative, as applicable) to the extent
8-K
EX-99.1
DYAI
Dyadic International Inc., DE
10 Nov 21
Dyadic Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
4:16pm
International – accelerated tech transfer of the DYAI-100 cell line has been completed, the manufacturing part of technology training on the C1 production
8-K
EX-10.1
tigk0
9 Nov 21
Dyadic Appoints Chief Business Officer to Executive Leadership Team
8:40am
8-K
EX-10.1
kje93f w20emf0azxj
29 Jun 20
Entry into a Material Definitive Agreement
8:04am
8-K
EX-99.2
14kzkymmzdpu22g4k3sj
18 Mar 20
Other Events
5:06pm
8-K
EX-10.1
yhijbffhbarlzz lcj
8 May 19
Dyadic Announces Sub-Licensing Agreement with Alphazyme
3:15pm
8-K
EX-99.1
fvwyunv3q7e
2 May 19
Dyadic Announces Sub-Licensing Agreement with Luina Bio
4:05pm
8-K
EX-10.1
501g7ocza0a ez
2 May 19
Dyadic Announces Sub-Licensing Agreement with Luina Bio
4:05pm
10-K
cle3b8 v5dpi7ip45rx6
27 Mar 19
Annual report
4:30pm
10-12G/A
zmjd8coskit45ipv
8 Feb 19
Registration of securities (amended)
5:26pm
10-12G
EX-10.6
d2khdu1 kfqms
14 Jan 19
Registration of securities
5:23pm
10-12G
EX-10.7
9lw9tojv r8tl54gu
14 Jan 19
Registration of securities
5:23pm
10-12G
EX-10.8
o7brz5ducs3
14 Jan 19
Registration of securities
5:23pm
10-12G
EX-10.12
x98zin5
14 Jan 19
Registration of securities
5:23pm